SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,785.00    90.00 (1.34%)
Bid:
6,780.00
Ask:
6,790.00
Spread: 10.00 (0.147%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

13 May 2008 12:00

RNS Number : 3064U
Spirax-Sarco Engineering PLC
13 May 2008
 

Spirax-Sarco Engineering plc

Tuesday 13th May 2008 

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the four month period ended 30th April 2008, ahead of its Annual General Meeting today at 2.00 pm.

Trading

Overall market conditions have remained favourable in 2008. We have seen sustained business investment by our customers and we continue to benefit from good progress with our ongoing sales initiatives.

The organic revenue growth trend has continued from last year through into 2008. Growth was spread across all geographic regions for both the Spirax Sarco and Watson-Marlow Bredel businesses. The euro has strengthened considerably since late last year which, together with other currency movements elsewhere, has benefited the translation into sterling of total Group revenues by approximately 6% overall, with a larger benefit to operating profit.

Corporate Developments

The integration of Flexicon with our Watson-Marlow Bredel business is proceeding well following completion of the acquisition on 11th February 2008 for £14m. As previously reported, Marcus Steel retired as Chief Executive as of 31st March 2008, as did Peter Smith, Director and Company Secretary. On 1st April Mark Vernon, previously Chief Operating Officer, succeeded Marcus as Chief Executive and William Stebbings succeeded Peter as Company Secretary.

Financial position

The Group started the year with net cash of £16m and has subsequently paid an initial £11m consideration for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period and we continue to operate with a strong balance sheet. As anticipated, we expect capital expenditure this year to be well above normal levels mainly due to the new premises in China.

 

Outlook

In our preliminary statement in early March, we reported that 2008 had started well and that, assuming our global markets remained stable, we expected to produce another good performance in 2008. Trading so far this year confirms this expectation, although there remains uncertainty about the resilience of the global economy, and in particular North America. If current exchange rates prevail for the remainder of the year, sales and profits, particularly in Continental Europe, will also benefit from good exchange gains.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 521361

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBGGDUCSBGGIX
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.